The US FDA is trying to secure supplies of ifosfamide, a cancer treatment in short supply due to manufacturing disruptions. IDMA is gathering information on potential Indian suppliers to address the ongoing drug shortage in the US. The US FDA is trying to secure supplies of ifosfamide, a cancer treatment in short supply due to manufacturing disruptions. IDMA is gathering information on potential Indian suppliers to address the ongoing drug shortage in the US. by Soban News (international And National News)
